2023
2026

Focused Expansion & Local Adaptation

To develop and distribute infectious disease diagnostic kits and rapid tests that are well-suited to deployment conditions in Vietnam, while further strengthening cooperation with Korean technology partners, including The Calth and Dagatronics.

2020
2021

Pandemic Response & Operational Resilience

Successfully deployed Abbott Alinity m systems and SARS-CoV-2 testing solutions during the COVID-19 pandemic, demonstrating strong rapidresponse capabilities and the ability to ensure continuity in laboratory operations.

2018
2019

Advanced Diagnostics & System Integration

Develop distribution and implementation capabilities for advanced diagnostic solutions through collaboration with MadgeTech (Canada), Slee (Germany), ElitechGroup (Italy), and Benchmark Scientific (USA).

2015
2016

Strengthening Global Technology Portfolio

Further strengthened partnerships with global biomedical technology leaders including Thermo Fisher Scientific (USA), JeioTech (Korea), Wealtec (Taiwan), Mettler Toledo (USA), and Biotix (USA), gradually completing an integrated laboratory solution ecosystem.

2011

Expansion into Life Sciences & Pathology

Expanded distribution portfolio to include Leica Microsystems (Germany) and Life Technologies (USA), strengthening capabilities in pathology, molecular biology, and life science technologies.

2010
2011

Foundation & Core Partnerships

Established LINTECH JSC and built the foundation as the official distributor of Abbott Molecular (USA), forming the basis for long-term operational capability in molecular diagnostics.